Skip to content

BLR Pharma: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BLR Pharma

BE 1012.884.490
NACE 70.200, Business and other management consultancy
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€6,604
2024 · €14,606-€8,002
Equity
€23,210
2024 · €16,606+€6,604
Cash
€20,541
2024 · €8,491+€12,050
Balance sheet total
€70,293
2024 · €61,451+€8,842

Largest movements

2024 to 2025
Assets
  • Cash +€12,050

    up €12,050 (+141.9%), from €8,491 to €20,541

    mainly Depreciation (+€18,172) and Tax, wage and social debts (+€8,249)

  • Tangible fixed assets -€5,909

    down €5,909 (-20.9%), from €28,301 to €22,392

    of which Furniture and vehicles: -€16,210

  • Receivables within one year +€4,496

    up €4,496 (+19.7%), from €22,864 to €27,360

  • Deferred charges and accrued income -€1,796

    no longer reported in 2025 (was €1,796)

Equity and liabilities
  • Debts after one year -€8,807

    down €8,807 (-35.4%), from €24,844 to €16,037

  • Tax, wage and social debts +€8,249

    up €8,249 (+94.6%), from €8,723 to €16,972

  • Profit (loss) carried forward +€6,604

    up €6,604 (+45.2%), from €14,606 to €21,210

  • Other debts +€4,177

    up €4,177 (+1041.2%), from €401 to €4,579

  • Trade debts -€1,633

    down €1,633 (-70.3%), from €2,322 to €689

Income statement
  • Depreciation +€14,053

    up €14,053 (+341.2%), from €4,119 to €18,172

  • Gross operating margin +€4,974

    up €4,974 (+18.9%), from €26,326 to €31,300

  • Other operating charges -€1,579

    down €1,579 (-59.6%), from €2,650 to €1,071

  • Financial charges +€634

    up €634 (+234.5%), from €270 to €904

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €14,606
Gross operating margin +€4,974
Depreciation -€14,053
Other operating charges +€1,579
Financial income +€35
Financial charges -€634
Taxes +€98
Result 2025 €6,604

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€32,869
Investment -€12,263
Financing -€8,556
Cash 2024 €8,491
Net result for the year +€6,604
Depreciation +€18,172
Receivables within one year -€4,496
Deferred charges and accrued income +€1,796
Trade debts -€1,633
Tax, wage and social debts +€8,249
Other debts +€4,177
Investment in fixed assets (net) -€12,263
Debts after one year -€8,807
Current portion of long-term debt +€251
Cash 2025 €20,541
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €61,451 €70,293 +€8,842 +14.4%
Fixed assets 21/28 €28,301 €22,392 -€5,909 -20.9%
Tangible fixed assets 22/27 €28,301 €22,392 -€5,909 -20.9%
Furniture and vehicles 24 €28,301 €12,091 -€16,210 -57.3%
Other tangible fixed assets 26 - €10,301 +€10,301
Current assets 29/58 €33,150 €47,901 +€14,751 +44.5%
Amounts receivable within one year 40/41 €22,864 €27,360 +€4,496 +19.7%
Trade receivables 40 €22,864 €27,360 +€4,496 +19.7%
Cash at bank and in hand 54/58 €8,491 €20,541 +€12,050 +141.9%
Deferred charges and accrued income 490/1 €1,796 - -€1,796
Total equity and liabilities 10/49 €61,451 €70,293 +€8,842 +14.4%
Equity 10/15 €16,606 €23,210 +€6,604 +39.8%
Contributions 10/11 €2,000 €2,000 = 0.0%
Profit (loss) carried forward 14 €14,606 €21,210 +€6,604 +45.2%
Amounts payable 17/49 €44,845 €47,084 +€2,238 +5.0%
Amounts payable after more than one year 17 €24,844 €16,037 -€8,807 -35.4%
Financial debts 170/4 €24,844 €16,037 -€8,807 -35.4%
Amounts payable within one year 42/48 €20,001 €31,046 +€11,045 +55.2%
Current portion of amounts payable after more than one year 42 €8,556 €8,807 +€251 +2.9%
Trade debts 44 €2,322 €689 -€1,633 -70.3%
Suppliers 440/4 €2,322 €689 -€1,633 -70.3%
Taxes, remuneration and social security 45 €8,723 €16,972 +€8,249 +94.6%
Taxes 450/3 €8,723 €16,972 +€8,249 +94.6%
Other amounts payable 47/48 €401 €4,579 +€4,177 +1041.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,119 €18,172 +€14,053 +341.2%
Other operating charges 640/8 €2,650 €1,071 -€1,579 -59.6%
Gross operating margin 9900 €26,326 €31,300 +€4,974 +18.9%
Operating profit (loss) 9901 €19,557 €12,057 -€7,500 -38.3%
Financial income 75/76B €0 €35 +€35 +345400.0%
Recurring financial income 75 €0 €35 +€35 +345400.0%
Financial charges 65/66B €270 €904 +€634 +234.5%
Recurring financial charges 65 €270 €904 +€634 +234.5%
Profit (loss) for the period before taxes 9903 €19,287 €11,187 -€8,099 -42.0%
Income taxes 67/77 €4,681 €4,583 -€98 -2.1%
Profit (loss) for the period 9904 €14,606 €6,604 -€8,002 -54.8%
Profit (loss) for the period to be appropriated 9905 €14,606 €6,604 -€8,002 -54.8%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.